The pharmaceutical industry is rapidly evolving, with growing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, stands as copyrightple of this trend. To meet this demand, US-based manufacturing services are emerging. These providers offer a wide-ranging suite of solutions, from research and